- Home
- AQST vs SDHY Comparison
AQST vs SDHY Comparison
Compare AQST & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- SDHY
- Stock Information
- Founded
- AQST 2004
- SDHY 2020
- Country
- AQST United States
- SDHY United States
- Employees
- AQST N/A
- SDHY N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- SDHY Finance/Investors Services
- Sector
- AQST Health Care
- SDHY Finance
- Exchange
- AQST Nasdaq
- SDHY Nasdaq
- Market Cap
- AQST 390.4M
- SDHY 415.2M
- IPO Year
- AQST 2018
- SDHY N/A
- Fundamental
- Price
- AQST $5.18
- SDHY $17.02
- Analyst Decision
- AQST Strong Buy
- SDHY
- Analyst Count
- AQST 7
- SDHY 0
- Target Price
- AQST $10.29
- SDHY N/A
- AVG Volume (30 Days)
- AQST 2.4M
- SDHY 94.0K
- Earning Date
- AQST 11-03-2025
- SDHY 01-01-0001
- Dividend Yield
- AQST N/A
- SDHY 8.46%
- EPS Growth
- AQST N/A
- SDHY N/A
- EPS
- AQST N/A
- SDHY 1.07
- Revenue
- AQST $44,132,000.00
- SDHY N/A
- Revenue This Year
- AQST N/A
- SDHY N/A
- Revenue Next Year
- AQST $38.71
- SDHY N/A
- P/E Ratio
- AQST N/A
- SDHY $14.31
- Revenue Growth
- AQST N/A
- SDHY N/A
- 52 Week Low
- AQST $2.12
- SDHY $13.93
- 52 Week High
- AQST $5.80
- SDHY $15.50
- Technical
- Relative Strength Index (RSI)
- AQST 68.04
- SDHY 56.77
- Support Level
- AQST $4.75
- SDHY $16.89
- Resistance Level
- AQST $5.27
- SDHY $17.18
- Average True Range (ATR)
- AQST 0.30
- SDHY 0.11
- MACD
- AQST 0.09
- SDHY -0.01
- Stochastic Oscillator
- AQST 75.40
- SDHY 46.67
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.